RETRACTED: Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer (Retracted Article)

被引:73
|
作者
Taylor, Douglas D. [1 ]
Gercel-Taylor, Cicek [1 ]
Parker, Lynn P. [1 ]
机构
[1] Univ Louisville, Sch Med, Div Gynecol Oncol, Dept Obstet Gynecol & Womens Hlth, Louisville, KY 40292 USA
关键词
Ovarian cancer; Early detection; Autoantibodies; CELL-LINES; P53; PROTEIN; HEPATOCELLULAR-CARCINOMA; IMMUNE-RESPONSE; HIGH-THROUGHPUT; BREAST-CANCER; AUTOANTIBODIES; ANTIGENS; IDENTIFICATION; BIOMARKERS;
D O I
10.1016/j.ygyno.2009.06.031
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Most ovarian cancers are diagnosed at advanced stage (67%) and prospects for significant improvement in survival reside in early diagnosis. Our objective was to validate our array assay for the identification of ovarian cancer based on quantitation of tumor-reactive IgG. Methods. The diagnostic array utilizes specific exosome-derived antigens to detect reactive IgG in patient's sera. Specific protein targets were isolated by immunoaffinity from exosomes derived from ovarian tumor cell lines. Sera were obtained from age-matched female volunteers, women with benign ovarian disease and with ovarian cancer. Immunoreactivity was also compared between exosomal proteins and their recombinant counterparts. Results. Sera from ovarian cancer patients exhibited significantly greater immunoreactivities than either normal controls or women with benign disease (both considered negative to all antigens tested). Reactivities with nucleophosmin, cathepsin D, p53, and SSX common antigen for patients with all stages of ovarian cancer were significantly higher than for controls and women with benign ovarian disease. Reactivity with placental type alkaline phosphatase, TAG 72, survivin, NY-ESO-1, GRP78, and Muc16 (CA125) allowed the differentiation between Stage III/IV and early stage ovarian cancer. Conclusions. The quantitation of circulating tumor-reactive IgG can be used to identify the presence of ovarian cancer. The analyses of IgG recognition of specific exosomal antigens allows for the differentiation of women with benign ovarian masses from ovarian cancer, as well as distinguishing early and late stage ovarian cancers. Thus, the quantitative assessment of IgG reactive with specific tumor-derived exosomal proteins can be used as diagnostic markers for ovarian cancer. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:112 / 120
页数:9
相关论文
共 50 条
  • [41] RETRACTED: Tumor-Derived Extracellular Vesicles Promote Activation of Carcinoma-Associated Fibroblasts and Facilitate Invasion and Metastasis of Ovarian Cancer by Carrying miR-630 (Retracted Article)
    Cui, Yulan
    Wang, Deying
    Xie, Min
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [42] Presence of aberrant tumor-reactive immunoglobulins in the circulation of patients with ovarian cancer
    Gerçel-Taylor, Ç
    Bazzett, LB
    Taylor, DD
    GYNECOLOGIC ONCOLOGY, 2001, 81 (01) : 71 - 76
  • [43] RETRACTED: Inhibition of Tumor Angiogenesis by Tumstatin: Insights into Signaling Mechanisms and Implications in Cancer Regression (Retracted Article)
    Sudhakar, Akulapalli
    Boosani, Chandra S.
    PHARMACEUTICAL RESEARCH, 2008, 25 (12) : 2731 - 2739
  • [44] RETRACTED: SphK1 promotes tumor cell migration and invasion in colorectal cancer (retracted article)
    Long, Jianting
    Xie, Ying
    Yin, Junmei
    Lu, Wei
    Fang, Shi
    TUMOR BIOLOGY, 2016, 37 (05) : 6831 - 6836
  • [45] RETRACTED: Characterization of Phosphoglycerate Kinase-1 Expression of Stromal Cells Derived from Tumor Microenvironment in Prostate Cancer Progression (Retracted Article)
    Wang, Jianhua
    Ying, Gigi
    Wang, Jingchen
    Jung, Younghun
    Lu, Jian
    Zhu, Jiang
    Pienta, Kenneth J.
    Taichman, Russell S.
    CANCER RESEARCH, 2010, 70 (02) : 471 - 480
  • [46] RETRACTED: Correlation of CD44v6 expression with ovarian cancer progression and recurrence (Retracted Article)
    Shi, Jun
    Zhou, Zhou
    Di, Wen
    Li, Ningli
    BMC CANCER, 2013, 13
  • [47] RETRACTED: Automatic Detection and Segmentation of Ovarian Cancer Using a Multitask Model in Pelvic CT Images (Retracted Article)
    Wang, Xun
    Li, Hanlin
    Zheng, Pan
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [48] RETRACTED: Prediction of Ovarian Cancer Response to Therapy Based on Deep Learning Analysis of Histopathology Images (Retracted Article)
    Liu, Yuexin
    Lawson, Barrett C.
    Huang, Xuelin
    Broom, Bradley M.
    Weinstein, John N.
    CANCERS, 2023, 15 (16)
  • [49] RETRACTED: MicroRNA-572/hMOF/Sirt6 regulates the progression of ovarian cancer (Retracted Article)
    Cai, Mingbo
    Hu, Zhenhua
    Han, Liping
    Guo, Ruixia
    CELL CYCLE, 2020, 19 (19) : 2509 - 2518
  • [50] RETRACTED: Effect of angiogenesis inhibitors on wound healing in patients with ovarian cancer: A meta-analysis (Retracted Article)
    Li, Xin
    Zeng, Deyang
    Shi, Jing
    INTERNATIONAL WOUND JOURNAL, 2024, 21 (03)